Latest Breaking News On - சார்ட்டர்ஹவுஸ் மூலதனம் கூட்டாளர்கள் - Page 3 : comparemela.com

3 Min Read PARIS (Reuters) - European private equity firm Charterhouse Capital Partners said on Friday it had entered exclusive talks to sell a majority stake in French drugmaker Cooperation Pharmaceutique Francaise, known as Cooper, to CVC Capital Partners. Slideshow ( 2 images ) The deal values the Paris-based firm at about 2.2 billion euros ($2.6 billion) and will see Charterhouse reinvesting in the business after having more than doubled its size since taking control in 2016, a source familiar with the matter told Reuters. Following the deal and reinvestment, Charterhouse will own about 20% of the firm, the source said. The London-based private equity firm is expected to return more than 1.2 billion euros to its investors when the deal completes, the source said.

France generalCity ofUnited kingdomPharmaceutique francaiseVincent pautetJan harveyJason neelyPamela barbagliaFreshfields bruckhaus deringerDominique vidalonThomson reuters trust principlesCharterhouse capital partnersCooperation pharmaceutique francaiseThomson reuters trustBanking amp investment services trbc level 2Company news